These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7221971)

  • 1. Clinico-pharmacological examinations with Ovidon.
    Farkas M
    Ther Hung; 1980; 28(3):118-28. PubMed ID: 7221971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of oral ovulation inhibiting (mono-, bi- and triphase) contraceptives and of Continuin and Postinor on proteo- and steroid hormones].
    Farkas M
    Acta Pharm Hung; 1992; 62(1-2):17-30. PubMed ID: 1566635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with hormonal contraceptives.
    Kulakov VI
    Acta Med Hung; 1986; 43(2):93-6. PubMed ID: 3588163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical observations with Rigevidon.
    Bálint S
    Ther Hung; 1980; 28(2):75-8. PubMed ID: 7466718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative data on the liver- and lipid metabolism influencing effects of Anteovin.
    Pilishegyi J
    Ther Hung; 1987; 35(2):71-6. PubMed ID: 3438865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical trial of the combined contraceptive preparation, Ovidon].
    Nalbanski B
    Akush Ginekol (Sofiia); 1979; 18(5):388-91. PubMed ID: 391067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
    Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
    Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The clinico-pharmacological characteristics of anteovin].
    Nikanorova SA; Kononova ES; Korkhov VV; Potin VV; Svechnikova FA; Boĭkova VV
    Farmakol Toksikol; 1991; 54(1):30-1. PubMed ID: 1860494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinico-pharmacological examination of Postinor (0.75 mg d-norgestrel).
    Farkas M; Apró G; Sas M
    Ther Hung; 1981; 29(1):22-30. PubMed ID: 7188237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen.
    Sitruk-Ware RL; Menard J; Rad M; Burggraaf J; de Kam ML; Tokay BA; Sivin I; Kluft C
    Contraception; 2007 Jun; 75(6):430-7. PubMed ID: 17519148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma prolactin concentrations in women treated with low dose combination type oral contraceptives and in women using a d-norgestrel-releasing intrauterine device.
    Nilsson CG; Lähteenmäki P
    Ann Clin Res; 1978 Aug; 10(4):242-5. PubMed ID: 707973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopharmacological examination of Anteovin.
    Farkas M; Szigethy A; Sas M
    Ther Hung; 1987; 35(1):14-8. PubMed ID: 3438859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oral contraceptives on vitamin B6 nutriture of young women.
    Vir SC; Love AH
    Int J Vitam Nutr Res; 1980; 50(1):29-34. PubMed ID: 7390712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early effect of a low dose (30 micrograms) ethinyl estradiol-containing Triphasil on vitamin B6 status. A follow-up study on six menstrual cycles.
    Massé PG; van den Berg H; Duguay C; Beaulieu G; Simard JM
    Int J Vitam Nutr Res; 1996; 66(1):46-54. PubMed ID: 8698546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women.
    Griffith SG; Dai Y
    Clin Ther; 2004 Dec; 26(12):2056-65. PubMed ID: 15823769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of oral contraceptive (ethinyl estradiol and d-norgestrel) on serum prolactin-oestradiol and progesterone levels.
    Erodogan M; Inal A; Ozgu M; Beksac MS; Ergurbuz I
    Acta Reprod Turc; 1980 Jan; 1(3):85-91. PubMed ID: 12262090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of hormonal contraceptives on menstrual and reproductive function of women].
    Dubnitskaia LV; Sotnikova EI
    Akush Ginekol (Mosk); 1990 Apr; (4):57-60. PubMed ID: 1696071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.